.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Metastatic Melanoma: The New Millennium

EP. 1: Systemic Therapy with T-VEC in Advanced Melanoma

December 16th 2015

EP. 2: Practical Application of T-VEC in Melanoma Treatment

December 16th 2015

EP. 3: Radiation Therapy and Abscopal Effect in Melanoma Treatment

December 16th 2015

EP. 4: Role of Surgery in the Management of Advanced Melanoma

December 16th 2015

EP. 5: Use of Immunotherapy Agents in Melanoma Treatment

December 16th 2015

EP. 6: Sequencing of Checkpoint Agents in Melanoma

December 16th 2015

EP. 7: Duration of Immunotherapy in Melanoma

December 16th 2015

EP. 8: Checkpoint Inhibitors: Combination Therapy in Melanoma

December 16th 2015

EP. 9: Combination Immunotherapy Treatment Duration in Melanoma Patients

December 16th 2015

EP. 10: Treatment of BRAF-Mutant Metastatic Melanoma

December 16th 2015

EP. 11: Sequencing Dual BRAF-MEK Inhibition and Immunotherapy

December 16th 2015

EP. 12: Duration of Dual BRAF-MEK Inhibition in Melanoma

December 16th 2015

EP. 13: Hot Versus Cold Tumors: Predictive Markers in Melanoma

December 16th 2015

EP. 14: Future Advances in Melanoma Treatment

December 16th 2015